• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰岛素抗体与1型糖尿病儿童及青少年的脂肪萎缩有关,但也与脂肪增生有关。

Insulin antibodies are associated with lipoatrophy but also with lipohypertrophy in children and adolescents with type 1 diabetes.

作者信息

Raile K, Noelle V, Landgraf R, Schwarz H P

机构信息

Children's Hospital, Ludwig-Maximilians-University of Munich, Munich, Germany.

出版信息

Exp Clin Endocrinol Diabetes. 2001;109(8):393-6. doi: 10.1055/s-2001-18991.

DOI:10.1055/s-2001-18991
PMID:11748486
Abstract

AIM

To evaluate clinical and immunological factors that are associated with lipodystrophy, i.e. lipoatrophy and lipohypertrophy, in diabetic children and adolescents.

METHODS

We investigated in a cross-sectional study 112 children and adolescents (age 1.1-19.1 yrs.) with type 1 diabetes. To grade lipodystrophy, we developed a clinical score ranging from normal (grade 0), moderate hypertrophy of subcutaneous tissue (grade 1), severe hypertrophy with increased density of tissue (grade 2) to lipoatrophy (grade 3). In all children, grade of lipodystrophy, antibodies against insulin (IA) or beta cell antigens (IA-2 and GAD) and clinical parameters were documented.

RESULTS

The antibodies against insulin (IA) increased significantly after diabetes manifestation and initiation of insulin treatment, while beta cell specific antibodies (IA-2, GAD) did not. Lipoatrophy (grade 3) was seen in 4 children, severe lipohypertrophy (grade 2) in 18 and moderate lipohypertrophy (grade 1) in 27 children. No alteration of injection sites was found in 63 children. Amongst clinical and immunological parameters, IA levels were significantly associated with hypertrophy or atrophy of injection sites.

CONCLUSION

The strong association of lipoatrophy and lipohypertrophy with insulin antibodies might suggest that autoimmune phenomena with insulin play a role in the development of both. Despite an association of IA and lipodystrophy in type 1 diabetic children, the causal link between the two remains unproven and requires further longitudinal exploration.

摘要

目的

评估与糖尿病儿童及青少年脂肪营养不良(即脂肪萎缩和脂肪肥大)相关的临床和免疫因素。

方法

我们对112例1型糖尿病儿童及青少年(年龄1.1 - 19.1岁)进行了一项横断面研究。为了对脂肪营养不良进行分级,我们制定了一个临床评分,范围从正常(0级)、皮下组织中度肥大(1级)、组织密度增加的重度肥大(2级)到脂肪萎缩(3级)。记录了所有儿童的脂肪营养不良分级、抗胰岛素抗体(IA)或β细胞抗原抗体(IA - 2和GAD)以及临床参数。

结果

糖尿病发病并开始胰岛素治疗后,抗胰岛素抗体(IA)显著增加,而β细胞特异性抗体(IA - 2、GAD)则没有。4例儿童出现脂肪萎缩(3级),18例出现重度脂肪肥大(2级),27例出现中度脂肪肥大(1级)。63例儿童未发现注射部位改变。在临床和免疫参数中,IA水平与注射部位的肥大或萎缩显著相关。

结论

脂肪萎缩和脂肪肥大与胰岛素抗体的强烈关联可能表明胰岛素相关的自身免疫现象在两者的发生中起作用。尽管1型糖尿病儿童中IA与脂肪营养不良有关联,但两者之间的因果关系仍未得到证实,需要进一步的纵向研究。

相似文献

1
Insulin antibodies are associated with lipoatrophy but also with lipohypertrophy in children and adolescents with type 1 diabetes.胰岛素抗体与1型糖尿病儿童及青少年的脂肪萎缩有关,但也与脂肪增生有关。
Exp Clin Endocrinol Diabetes. 2001;109(8):393-6. doi: 10.1055/s-2001-18991.
2
Sensitivity at diagnosis of combined beta-cell autoantibodies in insulin-dependent diabetic children. French Registry of IDDM in Children Study Group.胰岛素依赖型糖尿病儿童联合β细胞自身抗体诊断时的敏感性。法国儿童IDDM登记研究组。
Diabetes Metab. 1997 Apr;23(2):155-60.
3
The combination of antibodies to GAD-65 and IA-2ic can replace the islet-cell antibody assay to identify subjects at risk of type 1 diabetes mellitus.抗谷氨酸脱羧酶65(GAD-65)抗体和胰岛抗原2胞内区(IA-2ic)抗体联合检测可替代胰岛细胞抗体检测,用于识别1型糖尿病高危人群。
Horm Metab Res. 1999 Oct;31(10):564-9. doi: 10.1055/s-2007-978796.
4
High T cell responses to the glutamic acid decarboxylase (GAD) isoform 67 reflect a hyperimmune state that precedes the onset of insulin-dependent diabetes.对谷氨酸脱羧酶(GAD)67亚型的高T细胞反应反映了在胰岛素依赖型糖尿病发病之前的一种超免疫状态。
J Autoimmun. 1997 Apr;10(2):165-73. doi: 10.1006/jaut.1996.0124.
5
Prevalence of lipohypertrophy in insulin-treated diabetic patients and predisposing factors.胰岛素治疗的糖尿病患者中脂肪增生的患病率及易感因素。
Exp Clin Endocrinol Diabetes. 1996;104(2):106-10. doi: 10.1055/s-0029-1211431.
6
Poor beta-cell function after the clinical manifestation of type 1 diabetes in children initially positive for islet cell specific autoantibodies. The Childhood Diabetes in Finland Study Group.在最初胰岛细胞特异性自身抗体呈阳性的儿童1型糖尿病临床表现出现后,β细胞功能较差。芬兰儿童糖尿病研究小组。
Diabet Med. 1997 Jul;14(7):532-7. doi: 10.1002/(SICI)1096-9136(199707)14:7<532::AID-DIA403>3.0.CO;2-6.
7
Diminished IFN-gamma response to diabetes-associated autoantigens in children at diagnosis and during follow up of type 1 diabetes.1型糖尿病患儿在诊断时及随访期间对糖尿病相关自身抗原的γ干扰素反应减弱。
Diabetes Metab Res Rev. 2006 Nov-Dec;22(6):462-70. doi: 10.1002/dmrr.639.
8
[Autoantibodies to GAD65, IA2 and insulin in Czech children with type 1 diabetes].[捷克1型糖尿病儿童中针对谷氨酸脱羧酶65、胰岛抗原2和胰岛素的自身抗体]
Cas Lek Cesk. 2000 Sep 27;139(19):599-603.
9
IA-2 autoantibodies predict impending type I diabetes in siblings of patients.IA-2自身抗体可预测糖尿病患者兄弟姐妹中即将发生的I型糖尿病。
Diabetologia. 2002 Dec;45(12):1658-66. doi: 10.1007/s00125-002-0949-8. Epub 2002 Nov 12.
10
Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children.年幼以及人类白细胞抗原(HLA)标记物会增加糖尿病患儿抗体呈阳性的兄弟姐妹患1型糖尿病的进展风险。
J Autoimmun. 1998 Dec;11(6):643-50. doi: 10.1006/jaut.1998.0244.

引用本文的文献

1
Insulin-Induced Lipohypertrophy Treated With Liposuction: A Review of Case Reports.抽脂治疗胰岛素诱导的脂肪增生:病例报告综述
Plast Surg (Oakv). 2025 Feb;33(1):116-122. doi: 10.1177/22925503231198095. Epub 2023 Aug 30.
2
International Society for Pediatric and Adolescent Diabetes Clinical Practice Consensus Guidelines 2024: Diabetes Technologies - Insulin Delivery.国际儿童和青少年糖尿病学会2024年临床实践共识指南:糖尿病技术 - 胰岛素输注
Horm Res Paediatr. 2024;97(6):636-662. doi: 10.1159/000543034. Epub 2024 Dec 10.
3
LIPODYSTROPHY FREQUENCY ACCORDING TO INSULIN TREATMENT REGIMEN IN TYPE 2 DIABETIC PATIENTS: IS INSULIN INJECTION FREQUENCY MATTERS IN ANALOG INSULIN ERA?
2型糖尿病患者中根据胰岛素治疗方案划分的脂肪营养不良发生率:在胰岛素类似物时代胰岛素注射频率重要吗?
Acta Endocrinol (Buchar). 2022 Apr-Jun;18(2):202-208. doi: 10.4183/aeb.2022.202.
4
The Impact of Insulin-Induced Lipodystrophy on Glycemic Variability in Pediatric Patients with Type 1 Diabetes.胰岛素诱导性脂肪营养不良对1型糖尿病患儿血糖变异性的影响。
Children (Basel). 2022 Jul 20;9(7):1087. doi: 10.3390/children9071087.
5
Machine Learning Decision Support for Detecting Lipohypertrophy With Bedside Ultrasound: Proof-of-Concept Study.用于床边超声检测脂肪增生的机器学习决策支持:概念验证研究。
JMIR Form Res. 2022 May 6;6(5):e34830. doi: 10.2196/34830.
6
Insulin-induced Lipohypertrophy in Patients with Type 1 Diabetes Mellitus Treated with an Insulin Pump.胰岛素泵治疗的1型糖尿病患者中胰岛素诱导的脂肪增生
Int J Endocrinol. 2022 Jan 24;2022:9169296. doi: 10.1155/2022/9169296. eCollection 2022.
7
Characteristics and morphology of lipohypertrophic lesions in adults with type 1 diabetes with ultrasound screening: an exploratory observational study.成人 1 型糖尿病患者行超声筛查的脂性肥厚性病变的特征和形态:一项探索性观察性研究。
BMJ Open Diabetes Res Care. 2021 Dec;9(2). doi: 10.1136/bmjdrc-2021-002553.
8
The Injection Technique Factor: What You Don't Know or Teach Can Make a Difference.注射技术因素:你所不知道或未传授的内容可能会产生影响。
Clin Diabetes. 2019 Jul;37(3):227-233. doi: 10.2337/cd18-0076.
9
Factors Affecting the Absorption of Subcutaneously Administered Insulin: Effect on Variability.影响皮下注射胰岛素吸收的因素:对变异性的影响。
J Diabetes Res. 2018 Jul 4;2018:1205121. doi: 10.1155/2018/1205121. eCollection 2018.
10
An Effective Intervention for Diabetic Lipohypertrophy: Results of a Randomized, Controlled, Prospective Multicenter Study in France.一项针对糖尿病性脂肪营养不良的有效干预措施:法国一项随机、对照、前瞻性多中心研究的结果。
Diabetes Technol Ther. 2017 Nov;19(11):623-632. doi: 10.1089/dia.2017.0165. Epub 2017 Oct 23.